Propranolol or Beta-Blockers for Cerebral Cavernous Malformation: a Systematic Review and Meta-analysis of Literature in Both Preclinical and Clinical Studies

Effects of medication intake on the risk of hemorrhage in patients with sporadic cerebral cavernous malformations

(2023) Bixia Chen et al.   Frontiers in Neurology

Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations

(2022) Susanna M. Zuurbier et al.   STROKE

The Influence of Select Medications on Prospective Hemorrhage Risk in Patients with Spinal or Cerebral Cavernous Malformations

(2022) Lauren Previch et al.   World Neurosurgery

Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial

(2022) Silvia Lanfranconi et al.   LANCET NEUROLOGY

Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations

(2021) Joppe Oldenburg et al.   STROKE

Successful treatment of hemorrhagic brainstem cavernous malformation with hematoma evacuation and postoperative propranolol

(2020) Jessa E. Hoffman et al.   CHILDS NERVOUS SYSTEM

Role of aspirin and statin therapy in patients with cerebral cavernous malformations

(2020) Santiago Gomez-Paz et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models

(2020) Wenqing Li et al.   JOURNAL OF CLINICAL INVESTIGATION

Bleeding risk of cerebral cavernous malformations in patients on β-blocker medication: a cohort study

(2018) Johannes Goldberg et al.   JOURNAL OF NEUROSURGERY

Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage

(2016) Joseph M. Zabramski et al.   World Neurosurgery

A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma

(2015) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cerebral cavernous malformations in the setting of focal epilepsies: pathological findings, clinical characteristics, and surgical treatment principles

(2014) Lara E. Jehi et al.   ACTA NEUROPATHOLOGICA

The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action

(2014) Y. Ji et al.   BRITISH JOURNAL OF DERMATOLOGY

Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference

(2012) B. A. Drolet et al.   PEDIATRICS

The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study

(2011) Natalie A. de Morton   AUSTRALIAN JOURNAL OF PHYSIOTHERAPY

The natural history of intracranial cavernous malformations

(2011) Bradley A. Gross et al.   Neurosurgical Focus

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

(2010) C.H. Storch et al.   BRITISH JOURNAL OF DERMATOLOGY

Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

(2009) Marc Fisher et al.   STROKE